More articles from correspondence

Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
Lorenzo Guglielmetti, Gunar Günther, Claude Leu, Daniela Cirillo, Raquel Duarte, Alberto L. Garcia-Basteiro, Delia Goletti, Mateja Jankovic, Liga Kuksa, Florian P. Maurer, Frédéric Méchaï, Simon Tiberi, Frank van Leth, Nicolas Veziris, Christoph Lange

European Respiratory Journal May 2022, 59 (5) 2200388; DOI: 10.1183/13993003.00388-2022
Balancing the risks and benefits is essential for reaping the success of adding in-circuit bacterial filters
Sven Stieglitz, Mohanchandra Mandal, Pradipta Bhakta, Antonio M. Esquinas

European Respiratory Journal May 2022, 59 (5) 2200562; DOI: 10.1183/13993003.00562-2022
Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?
Alice Havette, Lucile Regard, Nicolas Roche, Pierre-Régis Burgel

European Respiratory Journal May 2022, 59 (5) 2102924; DOI: 10.1183/13993003.02924-2021
Reply: Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?
Ritesh Agarwal, Valliappan Muthu

European Respiratory Journal May 2022, 59 (5) 2102989; DOI: 10.1183/13993003.02989-2021
Reply: Methionine supplementation: potential for improving alveolar macrophage function through reverse cholesterol transport?
Alice Hadchouel, Christophe Delacourt

European Respiratory Journal May 2022, 59 (5) 2102937; DOI: 10.1183/13993003.02937-2021
Methionine supplementation: potential for improving alveolar macrophage function through reverse cholesterol transport?
Marissa O'Callaghan, Feargal Helly, Elizabeth Tarling, Michael P. Keane, Cormac McCarthy

European Respiratory Journal May 2022, 59 (5) 2102594; DOI: 10.1183/13993003.02594-2021
War in Ukraine: an immense threat to the fight against tuberculosis
Victor Dahl, Giovanni Battista Migliori, Christoph Lange, Christian Wejse

European Respiratory Journal Apr 2022, 59 (4) 2200493; DOI: 10.1183/13993003.00493-2022
Reply: Not all HDL particles are equal in idiopathic pulmonary fibrosis
Amisha V. Barochia, Scott D. Barnett, Nargues Weir, Stewart J. Levine, Steven D. Nathan

European Respiratory Journal Apr 2022, 59 (4) 2200151; DOI: 10.1183/13993003.00151-2022
Correlation of total serum HDL particles with a predictor of mortality risk in idiopathic pulmonary fibrosis
Taro Yasuma, Corina N. D'Alessandro-Gabazza, Hajime Fujimoto, Tetsu Kobayashi, Esteban C. Gabazza

European Respiratory Journal Apr 2022, 59 (4) 2103175; DOI: 10.1183/13993003.03175-2021
Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity
Sophie M. Poznanski, Ana Portillo, Manali Mukherjee, Anurag Bhalla, Kiho Son, Ali A. Ashkar, Nader Khalidi, Parameswaran Nair

European Respiratory Journal Apr 2022, 59 (4) 2102210; DOI: 10.1183/13993003.02210-2021

Main menu

User menu

Search

More articles from correspondence

Pages

Contact us